Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
Tricoli JV, Boardman LA, Patidar R, Sindiri S, Jang JS, Walsh WD, McGregor PM 3rd, Camalier CE, Mehaffey MG, Furman WL, Bahrami A, Williams PM, Lih CJ, Conley BA, Khan J. Tricoli JV, et al. Among authors: furman wl. Cancer. 2018 Mar 1;124(5):1070-1082. doi: 10.1002/cncr.31136. Epub 2017 Nov 30. Cancer. 2018. PMID: 29194591 Free PMC article.
Progress in the treatment of adolescents with acute lymphoblastic leukemia.
Rivera GK, Pui CH, Santana VM, Hancock ML, Mahmoud H, Sandlund JT, Ribeiro RC, Furman W, Marina N, Crist WM. Rivera GK, et al. Cancer. 1993 May 15;71(10 Suppl):3400-5. doi: 10.1002/1097-0142(19930515)71:10+<3400::aid-cncr2820711744>3.0.co;2-o. Cancer. 1993. PMID: 8490889
Disease control intervals in high-risk neuroblastoma.
Santana VM, Furman WL, McGregor LM, Billups CA. Santana VM, et al. Among authors: furman wl. Cancer. 2008 Jun 15;112(12):2796-801. doi: 10.1002/cncr.23507. Cancer. 2008. PMID: 18429000 Free article.
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
Stricker TP, Morales La Madrid A, Chlenski A, Guerrero L, Salwen HR, Gosiengfiao Y, Perlman EJ, Furman W, Bahrami A, Shohet JM, Zage PE, Hicks MJ, Shimada H, Suganuma R, Park JR, So S, London WB, Pytel P, Maclean KH, Cohn SL. Stricker TP, et al. Mol Oncol. 2014 May;8(3):669-78. doi: 10.1016/j.molonc.2014.01.010. Epub 2014 Jan 31. Mol Oncol. 2014. PMID: 24560446 Free PMC article.
Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.
Navid F, Herzog CE, Sandoval J, Daryani VM, Stewart CF, Gattuso J, Mandrell B, Phipps S, Chemaitilly W, Sykes A, Davidoff AM, Shulkin BL, Bahrami A, Furman WL, Mao S, Wu J, Schiff D, Rao B, Pappo A. Navid F, et al. Among authors: furman wl. Pediatr Blood Cancer. 2016 Jul;63(7):1207-13. doi: 10.1002/pbc.25983. Epub 2016 Apr 1. Pediatr Blood Cancer. 2016. PMID: 27038395 Free PMC article. Clinical Trial.
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma.
Furman WL, Federico SM, McCarville MB, Shulkin BL, Davidoff AM, Krasin MJ, Sahr N, Sykes A, Wu J, Brennan RC, Bishop MW, Helmig S, Stewart E, Navid F, Triplett B, Santana VM, Bahrami A, Anthony G, Yu AL, Hank J, Gillies SD, Sondel PM, Leung WH, Pappo AS. Furman WL, et al. Clin Cancer Res. 2019 Nov 1;25(21):6320-6328. doi: 10.1158/1078-0432.CCR-19-1452. Epub 2019 Oct 10. Clin Cancer Res. 2019. PMID: 31601569 Free PMC article. Clinical Trial.
Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort.
Wilson CL, Brinkman TM, Cook C, Huang S, Hyun G, Green DM, Furman WL, Bhakta N, Ehrhardt MJ, Krasin MJ, Robison LL, Ness KK, Hudson MM. Wilson CL, et al. Among authors: furman wl. Cancer. 2020 Mar 15;126(6):1330-1338. doi: 10.1002/cncr.32678. Epub 2020 Jan 10. Cancer. 2020. PMID: 31923330 Free PMC article.
191 results